CAROL GODOY: Open Payments
NPI 1760653885 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 24 payments from 9 companies in 2025. Trend: 2023 $801 · 2024 $794 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Amgen Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
Products named: AIRSUPRA, JARDIANCE, Kerendia, ENBREL, NEFFY, HETLIOZ, FANAPT, CRYSVITA.
Industry payments across CA — which companies pay providers there.
